Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Aug. 31, 2021	Aug. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,856,413)	$ (27,019,590)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount	0	1,614,006
Depreciation expense	0	4,413
Inventory write-off	0	76,366
Gain on Note Payable Forgiveness	(135,165)	0
Derivative (gain)/loss	0	20,614,658
Provision for bad debts	2,340	19,425
Changes in operating assets and liabilities:
Accounts receivable	18,834	(3,215)
Prepaid expenses	91,218	(50,667)
Inventory	125,340	433,761
Accounts payable and accrued liabilities	1,377,024	2,308,494
Cash used in operating activities	(376,822)	(2,002,349)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from PPP loan	0	135,165
Proceeds from convertible debt	0	936,168
Proceeds from NCI Investment in Brain Armor	300,000	0
Cash provided by financing activities	300,000	1,071,333
NET CHANGE IN CASH AND CASH EQUIVALENTS	(76,822)	(931,016)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	88,007	1,013,674
Cash balance	19,439	19,439
CASH AND CASH EQUIVALENTS AT END OF PERIOD	11,185	82,658
Cash paid for:
Income taxes	0	0
Interest	$ 0	$ 0